Back
SPDR® S&P Health Care Services ETF Vs. Range Cancer Therapeutics ETF Industry Stock Comparison
Sell
33
XHS
SPDR® S&P Health Care Services ETF
Last Price:
93.75
Seasonality Move:
6.32%
Buy
57
CNCR
Range Cancer Therapeutics ETF
Last Price:
14.74
Seasonality Move:
8.86%
Sell
33
SPDR® S&P Health Care Services ETF (XHS)
is a Sell
Is SPDR® S&P Health Care Services ETF a Buy, Sell or Hold?
- The current SPDR® S&P Health Care Services ETF [XHS] share price is $93.64. The Score for XHS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- XHS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Range Cancer Therapeutics ETF (CNCR)
is a Buy
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $14.96. The Score for CNCR is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- CNCR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XHS Stock Price Chart
What is SPDR® S&P Health Care Services ETF's stock price today?
-
The SPDR® S&P Health Care Services ETF share price today is $93.64
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XHS is experiencing selling pressure, which indicates risk of future bearish movement.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $14.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing slight buying pressure.
XHS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.59 | Sell |
| Relative Strength Index (14 RSI): | 45.73 | Sell |
| Chaikin Money Flow: | -11491 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (93.05 - 95.65) | Sell |
| Bollinger Bands (100): | (91.94 - 97.54) | Sell |
CNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 50.43 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.61 - 15.15) | Buy |
| Bollinger Bands (100): | (13.99 - 15.37) | Buy |
XHS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 93.52 | Buy |
| 20-day SMA: | 94.43 | Sell |
| 50-day SMA: | 95.74 | Sell |
| 200-day SMA: | 92.4 | Buy |
| 8-day EMA: | 93.74 | Sell |
| 20-day EMA: | 94.31 | Sell |
| 50-day EMA: | 94.92 | Sell |
| 200-day EMA: | 92.83 | Buy |
CNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.88 | Buy |
| 20-day SMA: | 14.93 | Buy |
| 50-day SMA: | 15.01 | Sell |
| 200-day SMA: | 15.04 | Sell |
| 8-day EMA: | 14.89 | Buy |
| 20-day EMA: | 14.93 | Buy |
| 50-day EMA: | 14.91 | Buy |
| 200-day EMA: | 14.57 | Buy |
SPDR® S&P Health Care Services ETF Earnings Growth & XHS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SPDR® S&P Health Care Services ETF Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Range Cancer Therapeutics ETF Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||